Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 139.60
Bid: 140.40
Ask: 141.00
Change: -1.80 (-1.27%)
Spread: 0.60 (0.427%)
Open: 143.20
High: 143.20
Low: 139.60
Prev. Close: 141.40
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - NCC Group Plc

24 Mar 2015 16:56

RNS Number : 3565I
Baillie Gifford & Co.
24 March 2015
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Baillie Gifford & Co

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NCC Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

24 March 2015

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

5,721,959

2.74

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

5,721,959

2.74

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

24 March 2015

Contact name:

Paul Salmond

Telephone number:

0131 275 3169

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETLLFERVEISFIE
Date   Source Headline
16th Sep 20229:35 amRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
31st Aug 20222:30 pmRNSTotal Voting Rights
29th Jul 20222:05 pmRNSBlock listing Interim Review
29th Jul 20222:00 pmRNSTotal Voting Rights
19th Jul 20223:00 pmRNSDirectorate Change
30th Jun 20222:00 pmRNSTotal Voting Rights
31st May 202212:21 pmRNSTotal Voting Rights
31st May 20227:00 amRNSUpdate regarding new Chief Executive Officer
9th May 20227:00 amRNSNew CEO appt; trading update; Notice Final Results
6th May 20229:35 amRNSDirector/PDMR Shareholding
29th Apr 20222:00 pmRNSTotal Voting Rights
13th Apr 202211:27 amRNSDirector/PDMR Shareholding
31st Mar 20222:00 pmRNSTotal Voting Rights
29th Mar 20227:00 amRNSBlock Listing Application
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
9th Mar 20221:52 pmRNSDirector/PDMR Shareholding
8th Mar 202211:52 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSTotal Voting Rights
4th Feb 20229:24 amRNSDirector/PDMR Shareholding
31st Jan 20221:35 pmRNSBlock listing Interim Review
31st Jan 20221:30 pmRNSTotal Voting Rights
27th Jan 20222:33 pmRNSDirector/PDMR Shareholding
27th Jan 20227:01 amRNSDirectorate Change
27th Jan 20227:00 amRNSHalf-year Report
26th Jan 20228:59 amRNSHolding(s) in Company
11th Jan 202212:27 pmRNSHolding(s) in Company
31st Dec 202110:00 amRNSTotal Voting Rights
30th Nov 20212:30 pmRNSTotal Voting Rights
24th Nov 20211:43 pmRNSDirector/PDMR Shareholding
24th Nov 202112:33 pmRNSDirector/PDMR Shareholding
23rd Nov 20213:51 pmRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSDirector/PDMR Shareholding
4th Nov 20215:32 pmRNSResult of AGM
4th Nov 20217:00 amRNSAGM Trading Statement
3rd Nov 20219:24 amRNSDirector/PDMR Shareholding
29th Oct 20218:01 amRNSTotal Voting Rights
28th Oct 20217:00 amRNSDirectorate Change
14th Oct 20219:03 amRNSDirector/PDMR Shareholding
13th Oct 202112:00 pmRNSDirector/PDMR Shareholding
5th Oct 20214:42 pmRNSDirector/PDMR Shareholding
30th Sep 20213:00 pmRNSTotal Voting Rights
29th Sep 20215:04 pmRNSDirector/PDMR Shareholding
29th Sep 20211:18 pmRNSNotice of AGM
14th Sep 20217:00 amRNSPreliminary results for the year ended 31 May 2021
20th Aug 20211:45 pmRNSHolding(s) in Company
30th Jul 20212:30 pmRNSBlock listing Interim Review
30th Jul 20212:00 pmRNSTotal Voting Rights
28th Jul 20217:00 amRNSChange to Full Year Results Announcement Date
20th Jul 20213:40 pmRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.